BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8239291)

  • 1. Decreased density of forebrain cholinergic neurons and disintegration of the spatial organization of behavior in experimental autoimmune dementia (EAD).
    Michaelson DM; Dubovik V; Faigon M; Eilam D; Feldon J
    Ann N Y Acad Sci; 1993 Sep; 695():244-8. PubMed ID: 8239291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased density of forebrain cholinergic neurons in experimental autoimmune dementia.
    Dubovik V; Faigon M; Feldon J; Michaelson DM
    Neuroscience; 1993 Sep; 56(1):75-82. PubMed ID: 8232919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disintegration of the spatial organization of behavior in experimental autoimmune dementia.
    Eilam D; Szechtman H; Faigon M; Dubovik V; Feldon J; Michaelson DM
    Neuroscience; 1993 Sep; 56(1):83-91. PubMed ID: 8232920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal model and in vitro studies of anti neurofilament antibodies mediated neurodegeneration in Alzheimer's disease.
    Oron L; Dubovik V; Novitsky L; Eilam D; Michaelson DM
    J Neural Transm Suppl; 1997; 49():77-84. PubMed ID: 9266416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an experimental autoimmune dementia model in the rat.
    Michaelson DM; Alroy G; Goldstein D; Chapman J; Feldon J
    Ann N Y Acad Sci; 1991; 640():290-4. PubMed ID: 1776754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease antibodies bind specifically to a neurofilament protein in Torpedo cholinergic neurons.
    Chapman J; Bachar O; Korczyn AD; Wertman E; Michaelson DM
    J Neurosci; 1989 Aug; 9(8):2710-7. PubMed ID: 2475591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antibodies to cholinergic neurons in Alzheimer's disease.
    Michaelson DM; Chapman J; Bachar O; Korczyn AD; Wertman E
    Prog Clin Biol Res; 1989; 317():689-94. PubMed ID: 2602432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brainstem auditory evoked potentials in experimental autoimmune dementia.
    Werber EA; Chapman J; Arlazoroff A
    Neurosci Lett; 1993 Mar; 151(2):234-6. PubMed ID: 8506086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies from Down's syndrome patients bind to the same cholinergic neurofilament protein recognized by Alzheimer's disease antibodies.
    Hassin-Baer S; Wertman E; Raphael M; Stark V; Chapman J; Michaelson DM
    Neurology; 1992 Mar; 42(3 Pt 1):551-5. PubMed ID: 1532232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to the heavy neurofilament subunit (NF-H) of Torpedo cholinergic neurons.
    Faigon M; Hadas E; Alroy G; Chapman J; Auerbach JM; Michaelson DM
    J Neurosci Res; 1991 Aug; 29(4):490-8. PubMed ID: 1791640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-neuronal antibodies similar to those found in Alzheimer's disease induce memory dysfunction in rats.
    Chapman J; Alroy G; Weiss Z; Faigon M; Feldon J; Michaelson DM
    Neuroscience; 1991; 40(2):297-305. PubMed ID: 2027463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome.
    Granholm AC; Sanders LA; Crnic LS
    Exp Neurol; 2000 Feb; 161(2):647-63. PubMed ID: 10686084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of rats with cholinergic neurons induces behavioral deficits.
    Chapman J; Feldon J; Alroy G; Michaelson DM
    J Neural Transplant; 1989; 1(2):63-76. PubMed ID: 2519521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.
    Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG
    Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to different isoforms of the heavy neurofilament protein (NF-H) in normal aging and Alzheimer's disease.
    Soussan L; Tchernakov K; Bachar-Lavi O; Yuvan T; Wertman E; Michaelson DM
    Mol Neurobiol; 1994; 9(1-3):83-91. PubMed ID: 7888108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
    Gibbs RB
    Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with cholinergic cell bodies induces histopathological changes in rat brains.
    Michaelson DM; Kadar T; Weiss Z; Chapman J; Feldon J
    Mol Chem Neuropathol; 1990; 13(1-2):71-80. PubMed ID: 2095784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does age matter? Behavioral and neuro-anatomical effects of neonatal and adult basal forebrain cholinergic lesions.
    De Bartolo P; Cutuli D; Ricceri L; Gelfo F; Foti F; Laricchiuta D; Scattoni ML; Calamandrei G; Petrosini L
    J Alzheimers Dis; 2010; 20(1):207-27. PubMed ID: 20164586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined damage to entorhinal cortex and cholinergic basal forebrain neurons, two early neurodegenerative features accompanying Alzheimer's disease: effects on locomotor activity and memory functions in rats.
    Traissard N; Herbeaux K; Cosquer B; Jeltsch H; Ferry B; Galani R; Pernon A; Majchrzak M; Cassel JC
    Neuropsychopharmacology; 2007 Apr; 32(4):851-71. PubMed ID: 16760925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to cholinergic neurons in Alzheimer's disease.
    Chapman J; Bachar O; Korczyn AD; Wertman E; Michaelson DM
    J Neurochem; 1988 Aug; 51(2):479-85. PubMed ID: 3292704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.